| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $1.77 | $1.56 | $1.39 | $1.64 | $1.60 | $1.42 | $1.22 | $2.23 |
| EPS (Diluted) | $1.77 | $1.56 | $1.39 | $1.64 | $1.59 | $1.42 | $1.21 | $2.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.4B | $14.0B | $13.1B | $13.0B | $13.1B | $10.9B | $8.3B | $7.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $13.5B | $12.4B | $11.6B | $11.7B | $11.3B | $9.2B | $7.0B | $6.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.9B | $1.6B | $1.5B | $1.3B | $1.8B | $1.7B | $1.2B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.3B | $0.3B | $0.4B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-1.0B | $-0.7B | $0.1B | $-0.8B | $-2.6B | $-1.3B | $-0.4B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.0B | $0.7B | $-0.2B | $0.3B | $2.1B | $1.5B | $0.3B | $-0.0B |